Medical records reveal clues to rare genetic disease in amish and mennonite populations
NCT ID NCT03159026
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked back at the medical records of 38 people who have a specific genetic form of propionic acidemia, a rare metabolic disorder. The goal was to describe how the condition progresses over time, especially heart problems, and to create a better plan for preventive care. No new treatments were tested; instead, researchers gathered information to guide future care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
38 people
The number who actually took part.
- Started
-
Apr 2017
- Finished
-
Sep 2022
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Amish and Mennonite individuals who have been diagnosed as having the PA-AMV form of propionic academia as characterized by the presence of homozygous PCCB c.1060A\>G.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients homozygous for the PCCB c.606A\>G mutation Exclusion Criteria: * Patients who are not homozygous for the PCCB c.1606A\>G mutation
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Propionic acidemia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, 15224, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Newborn screening study aims to catch rare diseases at birth
- Experimental gene therapy targets rare metabolic disease in toddlers
- New mRNA treatment for rare metabolic disease moves to Long-Term safety check
- Scientists launch Largest-Ever study to unravel rare metabolic disease
- MRNA therapy takes on rare metabolic disease
- No treatment, just data: new study tracks rare metabolic disease